Regulatory enrolment process (REP)

The Regulatory Enrolment Process (REP) facilitates the filing and processing of regulatory information related to:

  • company
  • dossier and product
  • regulatory activity
  • regulatory transaction

REP consists of web-based templates that capture information in a structured format. The REP templates replace existing Health Canada application and fee forms.

This process enables a move towards a common submission intake across product lines and allows Health Canada to automate the receipt and import of regulatory transactions into its repositories.

REP Summary Table
Product Line Version of the Regulatory Transaction Template Functional Pilot Production (voluntary use) Mandatory
Human Use Drugs (Pharmaceutical, Biologic and Radiopharmaceutical) and Disinfectants Current - v4.4.3 Closed Closed Current (Implemented Oct. 2020)
Medical Devices Current - v3.0.0 Closed Current (Implemented July 2024) 18 months from the production date
Clinical Trials N/A Date to be determined Date to be determined Date to be determined
Veterinary Drugs Current - v4.4.3 Closed Closed Current (Implemented Oct. 2022)

Human Drugs, Veterinary Drugs and Disinfectants

Templates, Stylesheets and Forms

Guidance documents and Notices

Medical Devices

Templates, Stylesheets and Forms

Guidance document and Notices

  • Guidance Document: The Regulatory Enrolment Process (REP): Medical Devices [2024-03-15] (available upon request no-reply.ereview.non-reponse@hc-sc.gc.ca). Please ensure the text 'Request for REP Guidance Document Medical Devices' is in the subject line of the email.

Related information

Contact us

If you have any questions regarding the Regulatory Enrolment Process, please contact us via email at: ereview@hc-sc.gc.ca

Page details

Date modified: